2 completed. 1 Phase 1, 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 1 | Completed 1 |
| Phase 2 | 1 | Completed 1 |
Follow Lyric Pharmaceuticals: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Efficacy, Safety, and Pharmacokinetics (PK) Study of Ulimorelin in Patients With Enteral Feeding Intolerance (EFI): The PROMOTE Trial Ulimorelin, Metoclopramide - Enteral Feeding Intolerance (EFI) | Phase 2 | Completed | Lyric Pharmaceuticals | 120 | 2016-10-01 | 2018-03-07 |
| A Study to Assess Ulimorelin in Healthy Subjects Ulimorelin, Placebo - Healthy Subjects | Phase 1 | Completed | Lyric Pharmaceuticals | 39 | 2015-01-01 | 2018-05-30 |
ulimorelin (2) · Metoclopramide (1)
Netherlands (1) · Spain (1) · United States (1)
2016 (1)